万泰生物 (603392)

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

ASH

Tags

300 Non-Cyclical IndexDeepSeekMSCI Component StocksSSE 180 IndexSSE Mid Cap IndexCSI 200 IndexInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareHelicobacter PyloriPrivate Enterprises 100 IndexCSI 300 IndexConsumption 100 IndexBiological ProductsBiological VaccinesMargin Trading and Securities LendingNon-Cyclical Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 126512.28
  • Circulating A-Shares(W): 126512.28
  • Earnings Per Share(RMB): -0.1400
  • Net Assets Per Share(RMB): 9.5560
  • Operating Revenue(W RMB): 149836.99
  • Total Profit(W RMB): -19185.64
  • **Net Profit Attributable to Parent(W RMB) **: -17342.20
  • Net Profit Growth Rate(%): -165.04
  • Weighted Return on Equity(%): -1.4200
  • Operating Cash Flow Per Share(RMB): 0.0060
  • Undistributed Profit Per Share(RMB): 5.5793
  • Capital Reserve Per Share(RMB): 2.4816

2. Main Business

The main business covers:

  • Research, development, production and sales of in vitro diagnostic reagents
  • Research, development, production and sales of instruments
  • Research, development, production and sales of vaccines

3. Company Basic Information

  • Company Name: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Listing Date: 2020-04-29
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 31 Kexueyuan Road, Changping District, Beijing
  • Website: https://www.ystwt.com
  • Company Profile: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. was established with Beijing Capital Venture Group as the main sponsor. Based on the audited net assets of 111.5008 million yuan as of October 31, 2007, it was converted into 55 million shares of the company's stock, with the remainder included in the company's capital reserve. The company is mainly engaged in the research, development, production and sales of in vitro diagnostic reagents, instruments and vaccines.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yangshengtang Co., Ltd. General Legal Person 70580.79 55.79
2 Hong Kong Securities Clearing Company Limited Northbound Capital 1289.91 1.02
3 Huatai-Pinebridge CSI 300 ETF Fund 640.61 0.51
4 China Merchants China Securities Biomedical Index Fund (LOF) Class A Fund 496.09 0.39
5 Harvest China Securities Vaccine and Biotechnology ETF Fund 31.94 0.03
6 ChinaAMC China Securities Vaccine and Biotech Index Fund Class A Fund 15.89 0.01
7 Penghua China Securities Vaccine and Biotech ETF Fund 12.50 0.01
8 Guotai China Securities Vaccine and Biotech ETF Fund 5.62 0.00
9 Yimi Kaitai Mixed Securities Investment Fund Class A Fund 3.56 0.00
10 China Merchants China Securities Vaccine and Biotechnology ETF Fund 2.82 0.00

5. Concept Sectors

  • Biological Vaccines
  • Helicobacter Pylori
  • Innovative Drugs
  • DeepSeek

Remarks

  • Data update date: 2025-11-02
  • Data source: Public Market Information